mezigdomide: a novel celmod showing promise in the treatment of r/r myeloma
Published 5 months ago • 192 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
6:32
cc-92480: a novel celmod, in r/r myeloma
-
1:59
the growing importance of celmods in the treatment of r/r multiple myeloma
-
1:55
recent updates on celmods in multiple myeloma
-
1:40
vulnerabilities in lipid synthesis pathways and resistance to imids and celmods in multiple myeloma
-
2:31
benefits of celmods over imids in multiple myeloma
-
1:02
cc-92480 (mezigdomide) in r/r mm
-
1:59
real-world outcomes of ide-cel in heavily pre-treated r/r mm
-
2:15
novel immunotherapies for the treatment of multiple myeloma
-
5:19
the current treatment landscape for multiple myeloma and trials investigating novel combinations
-
30:14
hematology analyzer installation and operation video
-
5:43
what is a celmod? how is it different from and imid? #myeloma
-
3:19
development of a novel next generation myeloma-specific liquid biopsy approach
-
2:07
challenges associated with the management of extramedullary myeloma & ongoing research
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
1:10
latest developments in the treatment of emd in myeloma
-
1:09
an update on alliance a061202: addition of ixazomib to pomalidomide-dexamethasone in r/r myeloma
-
2:13
novel agents in development for multiple myeloma: celmods, antibody-drug conjugates, and peptides
-
1:14
promising novel agents in aml: menin inhibitors
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
0:53
the future of next-generation sequencing assays in myeloma treatment